Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CYLD leads to the deubiquitination of IKKgamma subunit. 1 / 1

| 1

➶

reach

"The tumor suppressor CYLD inhibits the NF-kappaB pathway at multiple steps by deubiquitinating the IKKgamma subunit, TRAF2, TRAF6, and BCL3 (Brummelkamp et al., 2003; Kovalenko et al., 2003; Massoumi [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

17692804

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...